eGenesis Announces IND Clearance for EGEN-2784 in Kidney Transplant

The IND clearance supports a Phase 1/2/3 study to determine the safety and efficacy of their porcine-derived kidney in patients with dialysis-dependent ESKD, over the age of 50, who are currently on a transplant waitlist.

Read the full article » | Posted 09-15-2025

Related Articles

• Byonyks’ X1 APD Cycler Received FDA 510(k) Approval Last Summer Posted 02-17-2026
• FDA granted 510(k) approval to Outset for Next generation Tablo with Cybersecurity Posted 02-17-2026
• Drs. Monica Farcus and Jeffrey Perl Win the Mitchell Award for Health System Innovation Posted 01-16-2026
• Nephrodite Wins FDA Breakthrough Device Designation for “Holly” Posted 01-16-2026